InsidersTradesSigma
Total declarations
Company
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
5
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.2%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Greenspan Ira Scott, Président du Conseil. Officer active across 1 company, notably Scopus BioPharma Inc.. Aggregated, 5 filings have been recorded. Breakdown: 5 buys · 0 sell. Total volume traded: €17k. Activity tracked since 23 July 2021. The latest transaction was disclosed on 27 August 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Greenspan Ira Scott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
110 shares@ US$4.922.7% of flowCommon Stock, par value $0.001SEC:0001104659-21-110764:0
Canonical exit: 25 Nov 2021 (T+90)
500 shares@ US$4.4110.9% of flowCommon Stock, par value $0.001SEC:0001104659-21-109182:0
Canonical exit: 21 Nov 2021 (T+90)
2,000 shares@ US$4.0440.1% of flowCommon Stock, par value $0.001SEC:0001104659-21-108376:0
Canonical exit: 17 Nov 2021 (T+90)
1,000 shares@ US$4.1320.5% of flowCommon Stock, par value $0.001SEC:0001104659-21-107826:0
Canonical exit: 15 Nov 2021 (T+90)
1,100 shares@ US$4.7725.8% of flowCommon Stock, par value $0.001SEC:0001104659-21-096344:0
Canonical exit: 21 Oct 2021 (T+90)
5 of 5 declarations
About Greenspan Ira Scott
Ira Scott Greenspan is the Chairman of the Board of Scopus BioPharma Inc. He oversees the board's activities and ensures good governance of the company. His experience in the biopharmaceutical sector is valuable in guiding Scopus's strategy.
